Sign in
Username
Password
Lost your password?
Login
Login with Facebook
Login with Google
Login with LinkedIn
(close)
Search for:
Sign in
Register
Country Reports
InFocus
Europe
Asia-Pacific
Americas
Middle East & Africa
Legal & Regulatory
Sign in / Register
Country Reports
Americas
Asia-Pacific
Europe
Middle East & Africa
Vaccines
Legal & Regulatory
Shop
Search for:
Library
Contributions
China
COVID-19
Cell & Gene Therapy
Vaccines
News Releases
Facts & Figures
Directory
Shop
Tagged with France
HiFiBiO CEO on the Keys to Global Biotech Success
HiFiBiO Therapeutics cofounder, CEO and CSO Dr Liang Schweizer fits the profile of a Chinese biotech CEO to a T: advanced degrees in different…
Save
Share
Liang Schweizer – CEO & CSO, HiFiBiO Therapeutics
Dr Liang Schweizer introduces immunotherapy-focused biotech HiFiBiO Therapeutics, the main advantages of the company’s unique single-cell technology…
Save
Share
France: ‘Humiliation’ & the Sanofi-Pfizer Vaccine Deal;…
The latest from French pharma where Sanofi has inked a deal to produce 125 million doses of Pfizer’s COVID-19 vaccine as it faces delays with its…
Save
Share
Ipsen CEO David Loew on M&A, Rare Disease Expansion, Niche…
In a wide-ranging and exclusive interview with PharmaBoardroom, Ipsen CEO David Loew looks back on an atypical first 100 days at the helm of the…
Save
Share
France: Mid-2021 for Sanofi COVID-19 Vaccine; 1 Million Domestic…
A roundup of the latest stories from French pharma, including the progress of Sanofi’s COVID-19 vaccine, how Ipsen has managed to achieve sales…
Save
Share
French Pharma News Roundup August 2020
A roundup of some of the latest from French pharma, including Sanofi’s bumper Prinicipia deal, how Unither’s new Chinese acquisition catapults it…
Save
Share
Sanofi Buys Principia for USD 3.7 Billion as Part of Specialty…
Sanofi has agreed a deal to buy out its partner, US biotech company Principia Biopharma for USD 3.7 billion in cash, giving the French giant full…
Save
Share
Sanofi Pasteur Appoints Thomas Triomphe as New Executive Vice…
With former head David Loew moving to the CEO position at Ipsen, Sanofi appointed French national Thomas Triomphe as the new head of its vaccines…
Save
Share
Sanofi Makes USD 679 Million Investment in French Vaccine…
French pharma giant Sanofi is pivoting its focus to invest more heavily in vaccines with a plan to invest USD 679 million in vaccine manufacturing…
Save
Share
Skyepharma’s David Lescuyer on Manufacturing & Supply…
David Lescuyer, managing director of fully integrated French CDMO Skyepharma, outlines how the COVID-19 crisis could usher in a new era for the…
Save
Share
New CEO for Ipsen as David Loew Makes Switch From Sanofi Pasteur
David Loew, formerly executive vice president of Sanofi Pasteur, Sanofi's vaccines division, was appointed CEO of fellow French firm Ipsen on the 28th…
Save
Share
France & Germany: A New European Approach to Health Crises
Emmanuel Macron and Angela Merkel recently put their heads together to come up with a health strategy that would ensure greater European access to…
Save
Share
Page: 1 |
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
interviews
{"post_type":["article","interviews","legal_article","facts","infocus","sponsored"],"post_status":"publish","posts_per_page":12,"max_num_pages":-1,"paged":1,"meta_query":[{"key":"related","value":" France","compare":"LIKE"}]}
We use cookies to ensure that we give you the best experience on our site. For more info
click here
ACCEPT